ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 116 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,197,963 | +57.3% | 248,398 | +100.0% | 0.01% | -14.3% |
| Q4 2021 | $2,669,000 | -67.3% | 124,198 | +12.4% | 0.01% | -69.6% |
| Q3 2021 | $8,161,000 | -29.9% | 110,493 | -48.1% | 0.02% | +35.3% |
| Q2 2021 | $11,638,000 | +66.7% | 212,844 | +124.8% | 0.02% | -19.0% |
| Q1 2021 | $6,983,000 | -2.7% | 94,698 | +13.7% | 0.02% | -8.7% |
| Q4 2020 | $7,179,000 | +154.1% | 83,278 | +11.3% | 0.02% | +130.0% |
| Q3 2020 | $2,825,000 | – | 74,851 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $46,559,640 | 13.20% |
| Vivo Capital, LLC | 4,220,048 | $20,256,230 | 2.22% |
| Logos Global Management LP | 1,000,000 | $4,800,000 | 0.64% |
| Orbimed Advisors | 2,871,000 | $13,780,800 | 0.29% |
| Redmile Group, LLC | 1,283,289 | $6,159,787 | 0.29% |
| BRAIDWELL LP | 1,249,900 | $5,999,520 | 0.19% |
| Cormorant Asset Management, LP | 612,079 | $2,937,979 | 0.17% |
| Nan Fung Group Holdings Ltd | 41,950 | $201,360 | 0.16% |
| Forefront Analytics, LLC | 13,769 | $66,092 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 35,071 | $168,341 | 0.03% |